How much weight loss can you expect in 3 months on Wegovy?

The three-month decision: dose schedule shapes what's possible

The titration schedule for Wegovy runs 0.25 mg, then 0.5 mg, then 1.0 mg, then 1.7 mg, before reaching the 2.4 mg maintenance dose. In practice, most people spend the first three months on the lower rungs, and that matters when you're weighing up cost against expected results. The bulk of weight loss in clinical trials accrued as participants reached and stayed at maintenance dose. If you're trying to understand how much weight loss to expect from Wegovy in a month, it helps to know which month in the schedule you're actually talking about, since early months on starter doses look very different from later months at maintenance. For a fuller picture of what the first quarter typically delivers, how much you can lose on Wegovy in three months sets out what the evidence shows across that specific window. That shift has real value; it's just not the full picture.

A broader breakdown of Wegovy weight-loss outcomes can help set a realistic timeline, particularly if you're trying to understand where three months sits within the overall trajectory. The NICE technology appraisal for semaglutide (TA875) also sets out the evidence base that informed UK clinical recommendations, worth reading if you want to understand how the NHS evaluated this medicine's effectiveness before recommending it.

How UK private pricing for Wegovy is structured, and what headline figures often leave out

Private Wegovy pricing in the UK is set per pen, and the pen you need changes as your dose increases. Starter pens cost less than maintenance pens; a three-month supply therefore spans more than one price point. Many published prices cover the medicine itself but not the consultation, the prescription, aftercare support, or delivery, and understanding what the full cost of Wegovy actually includes is worth doing before you assume any two providers are quoting on the same basis. Before comparing figures, it's worth opening a provider's checkout and checking what the total actually includes, that takes less than a minute and the difference is often surprising.

Since Eli Lilly raised Mounjaro's UK list price in September 2025, the broader GLP-1 market has seen pricing shift; Wegovy prices across private providers have similarly varied, typically falling in a range that reflects dose and service model rather than any fixed market rate. Current Wegovy pricing context covers this in more detail, including what components a legitimate price should contain. No credible source can offer these medicines without a valid prescription following clinical assessment, anyone pricing far below the market without explaining what the clinical pathway looks like is a provider worth scrutinising carefully.

Where nume sits on price, and what that buys at three months

Choosing where to start Wegovy for three months involves a genuine cost-benefit calculation, and it's one only you can make. We don't win that comparison on headline price; that's a deliberate position. One transparent price at nume covers the consultation, the prescriber's review, the prescription, the medicine, and free next-working-day delivery, nothing surfaces at checkout that wasn't visible at the start. The aftercare is included too, which matters more at three months than people often expect: dose changes, questions about side effects, and the clinical re-review before every repeat all sit within that same price rather than being billed separately.

What we'd push back on is treating the lowest listing as the right answer for a prescription medicine. The clinical assessment that a GPhC-registered prescriber carries out before every order isn't an administrative formality; it's the check that keeps treatment safe. Our FAQs explain what that review involves if you want the detail. For a medicine that works over months and requires titration managed by a qualified clinician, the right question at three months isn't which provider charged the least, it's which one you'd trust to review your progress and adjust your treatment safely. You can verify any online pharmacy's registration at the GPhC pharmacy register; our premises number is 9012878.

What 'cheapest' doesn't answer when you're three months in

By month three, most people on Wegovy have a clearer sense of how the medicine is working for them. That's also the point where aftercare quality becomes tangible: is someone reviewing your repeat clinically, or is it automated? Is there a prescriber you can actually reach if something feels off? These are the questions that separate services rather than the per-pen price on the landing page. The MHRA has warned publicly about counterfeit weight-loss pens sold online, including some that have caused hospitalisations. Fake pens look convincing. The protection against them is a verified, GPhC-registered pharmacy sourcing through the licensed UK supply chain, not a discount.

If you're three months in and wondering whether your results are on track, looking at how much weight loss is typical in one month on Wegovy can help you judge whether your progress across the quarter adds up to what the evidence would suggest. For those thinking further ahead, six-month outcomes show how results continue to compound as doses reach maintenance levels. The full treatment picture (including how Wegovy compares to other licensed options) is on our treatment overview page, where you can also start your free consultation if you're ready to speak to a prescriber.